/ Print /

Business Strategy

Healthcare spending is slowing: Here’s whyA Robert Wood Johnson Foundation expert analyzes the Altarum Institute’s study on healthcare growth findings.
Genetic testing in oncology: 5 things payers should knowAs genomics continues to evolve, here are five things to know about genetic testing and counseling.
Five ways healthcare executives can better support physiciansA survey explores how physicians perceive their role in the healthcare system, and the findings aren’t good.
Consumers’ top 4 concerns about their physiciansA Physicians Foundation survey gives healthcare executives behind the scenes insight into the physician-patient relationship.
Game-changing gene therapies present cost problems for health execsCAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.
Four ways health execs can prep for costly CAR-T cell therapiesWith the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.
Payers can predict budget implications of high-cost drugs in the pipelineA University of Massachusetts clinical consulting pharmacist shows how assessing budget implications can be accomplished.
Payers need access to pre-approval drug informationPre-drug-approval forecasting and budgeting is increasingly important for payers. Is a safe harbor for manufacturers necessary?
Five ways to increase physician engagementOne expert says incentive programs to motivate physicians miss the mark. Here’s what he recommends instead.
Program uses provider, patient incentives to fight opioid epidemicProviders are coming up short when it comes to HEDIS measures related to substance abuse. Here’s how one health plan is changing that.